Activation of Toll-like Receptor-2 by Endogenous Matrix Metalloproteinase-2 Modulates Dendritic-Cell-Mediated Inflammatory Responses

Cell Reports

Volumn 9, Issue 5, 2014, Pages 1856-1870

  Godefroy, Emmanuelle ^a   Gallois, Anne ^a   Idoyaga, Juliana ^a,b,c   Merad, Miriam ^a   Tung, Navpreet ^a   Monu, Ngozi ^d   Saenger, Yvonne ^a   Fu, Yichun ^a   Ravindran, Rajesh ^e   Pulendran, Bali ^e   Jotereau, Francine ^f   Trombetta, Sergio ^d   Bhardwaj, Nina ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Team 12   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; OX40 LIGAND; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; GELATINASE B; LIPOPOLYSACCHARIDE; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; PROTEIN BINDING; TLR2 PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TNFSF4 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EMBRYO; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; T LYMPHOCYTE; TH2 CELL; UPREGULATION; ANIMAL; C57BL MOUSE; ENZYMOLOGY; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DENDRITIC CELLS; HEK293 CELLS; HUMANS; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE, INBRED C57BL; NF-KAPPA B; OX40 LIGAND; PROTEIN BINDING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84915766493     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.10.067     Document Type: Article

References (67)

1. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., Pulendran B. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J.Immunol. 2003, 171:4984-4989.
2. Akamatsu T., Watanabe N., Kido M., Saga K., Tanaka J., Kuzushima K., Nishio A., Chiba T. Human TSLP directly enhances expansion of CD8+ Tcells. Clin. Exp. Immunol. 2008, 154:98-106.
3. Akashi S., Saitoh S., Wakabayashi Y., Kikuchi T., Takamura N., Nagai Y., Kusumoto Y., Fukase K., Kusumoto S., Adachi Y., et al. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J.Exp. Med. 2003, 198:1035-1042.
4. Allen J.E., Maizels R.M. Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol. 2011, 11:375-388.
5. Arima K., Watanabe N., Hanabuchi S., Chang M., Sun S.C., Liu Y.J. Distinct signal codes generate dendritic cell functional plasticity. Sci. Signal. 2010, 3:ra4.
6. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., Cheng G., Yamasaki S., Saito T., Ohba Y., et al. Induction of colonic regulatory Tcells by indigenous Clostridium species. Science 2011, 331:337-341.
7. Bian J., Sun Y. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell. Biol. 1997, 17:6330-6338.
8. Brooks P.C., Strömblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., Cheresh D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996, 85:683-693.
9. Brooks P.C., Silletti S., von Schalscha T.L., Friedlander M., Cheresh D.A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 1998, 92:391-400.
10. Cayrol C., Girard J.P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 2009, 106:9021-9026.
11. Chen F., Liu Z., Wu W., Rozo C., Bowdridge S., Millman A., Van Rooijen N., Urban J.F., Wynn T.A., Gause W.C. An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat. Med. 2012, 18:260-266.
12. Chuang T., Ulevitch R.J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 2001, 1518:157-161.
13. Conant K., St Hillaire C., Nagase H., Visse R., Gary D., Haughey N., Anderson C., Turchan J., Nath A. Matrix metalloproteinase 1 interacts with neuronal integrins and stimulates dephosphorylation of Akt. J.Biol. Chem. 2004, 279:8056-8062.
14. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
15. D'Angelo M., Billings P.C., Pacifici M., Leboy P.S., Kirsch T. Authentic matrix vesicles contain active metalloproteases (MMP). a role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-beta. J.Biol. Chem. 2001, 276:11347-11353.
16. DeNardo D.G., Barreto J.B., Andreu P., Vasquez L., Tawfik D., Kolhatkar N., Coussens L.M. CD4(+) Tcells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009, 16:91-102.
17. Di Stefano A.B., Iovino F., Lombardo Y., Eterno V., Höger T., Dieli F., Stassi G., Todaro M. Survivin is regulated by interleukin-4 in colon cancer stem cells. J.Cell. Physiol. 2010, 225:555-561.
18. Dillon S., Agrawal A., Van Dyke T., Landreth G., McCauley L., Koh A., Maliszewski C., Akira S., Pulendran B. A Toll-like receptor 2 ligand stimulates Th2 responses invivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J.Immunol. 2004, 172:4733-4743.
19. Dufour A., Sampson N.S., Zucker S., Cao J. Role of the hemopexin domain of matrix metalloproteinases in cell migration. J.Cell. Physiol. 2008, 217:643-651.
20. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
21. Gerold G., Abu Ajaj K., Bienert M., Laws H.J., Zychlinsky A., de Diego J.L. A Toll-like receptor 2-integrin beta3 complex senses bacterial lipopeptides via vitronectin. Nat. Immunol. 2008, 9:761-768.
22. Godefroy E., Moreau-Aubry A., Diez E., Dreno B., Jotereau F., Guilloux Y. alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen. J.Exp. Med. 2005, 202:61-72.
23. Godefroy E., Manches O., Dréno B., Hochman T., Rolnitzky L., Labarrière N., Guilloux Y., Goldberg J., Jotereau F., Bhardwaj N. Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway. Cancer Cell 2011, 19:333-346.
24. Guan Y., Ranoa D.R., Jiang S., Mutha S.K., Li X., Baudry J., Tapping R.I. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J.Immunol. 2010, 184:5094-5103.
25. Han S., Koo J., Bae J., Kim S., Baik S., Kim M.Y. Modulation of TNFSF expression in lymphoid tissue inducer cells by dendritic cells activated with Toll-like receptor ligands. BMB Rep. 2011, 44:129-134.
26. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
27. Harris H.E., Andersson U., Pisetsky D.S. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat. Rev. Rheumatol. 2012, 8:195-202.
28. Hasan U., Chaffois C., Gaillard C., Saulnier V., Merck E., Tancredi S., Guiet C., Brière F., Vlach J., Lebecque S., et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J.Immunol. 2005, 174:2942-2950.
29. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zähringer U., Beutler B. CD36 is a sensor of diacylglycerides. Nature 2005, 433:523-527.
30. Hofmann U.B., Westphal J.R., Van Muijen G.N., Ruiter D.J. Matrix metalloproteinases in human melanoma. J.Invest. Dermatol. 2000, 115:337-344.
31. Houghton A.M., Hartzell W.O., Robbins C.S., Gomis-Rüth F.X., Shapiro S.D. Macrophage elastase kills bacteria within murine macrophages. Nature 2009, 460:637-641.
32. Incorvaia L., Badalamenti G., Rini G., Arcara C., Fricano S., Sferrazza C., Di Trapani D., Gebbia N., Leto G. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. Anticancer Res. 2007, 27(3B):1519-1525.
33. Ito T., Wang Y.H., Duramad O., Hori T., Delespesse G.J., Watanabe N., Qin F.X., Yao Z., Cao W., Liu Y.J. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J.Exp. Med. 2005, 202:1213-1223.
34. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
35. Kim S., Takahashi H., Lin W.W., Descargues P., Grivennikov S., Kim Y., Luo J.L., Karin M. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009, 457:102-106.
36. Kulbe H., Chakravarty P., Leinster D.A., Charles K.A., Kwong J., Thompson R.G., Coward J.I., Schioppa T., Robinson S.C., Gallagher W.M., et al. A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Res. 2012, 72:66-75. Australian Ovarian Cancer Study Group.
37. Larsen H., Muz B., Khong T.L., Feldmann M., Paleolog E.M. Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RA. Arthritis Res. Ther. 2012, 14:R180.
38. Lee H.K., Dunzendorfer S., Tobias P.S. Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation. J.Biol. Chem. 2004, 279:10564-10574.
39. Li D.Q., Zhang L., Pflugfelder S.C., De Paiva C.S., Zhang X., Zhao G., Zheng X., Su Z., Qu Y. Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways. J.Allergy Clin. Immunol. 2011, 128:1318.e2.
40. Lima A.C., Francelin C., Ferrucci D.L., Stach-Machado D.R., Verinaud L. Thymic alterations induced by Plasmodium berghei: expression ofmatrix metalloproteinases and their tissue inhibitors. Cell. Immunol. 2012, 279:53-59.
41. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980, 284:67-68.
42. Lu C.Y., Lai S.C. Induction of matrix metalloproteinase-2 and -9 via Erk1/2-NF-κB pathway in human astroglia infected with Toxoplasma gondii. Acta Trop. 2013, 127:14-20.
43. Lutz M.B., Kukutsch N., Ogilvie A.L., Rössner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J.Immunol. Methods 1999, 223:77-92.
44. May M.J., D'Acquisto F., Madge L.A., Glöckner J., Pober J.S., Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000, 289:1550-1554.
45. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., Furusawa J., Ohtani M., Fujii H., Koyasu S. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
46. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K., Bucks C., Kane C.M., Fallon P.G., Pannell R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
47. Oakley M.S., Sahu B.R., Lotspeich-Cole L., Solanki N.R., Majam V., Pham P.T., Banerjee R., Kozakai Y., Derrick S.C., Kumar S., Morris S.L. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria. J.Immunol. 2013, 191:4699-4708.
48. Ohno T., Oboki K., Kajiwara N., Morii E., Aozasa K., Flavell R.A., Okumura K., Saito H., Nakae S. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J.Immunol. 2009, 183:7890-7897.
49. Oppenheim J.J., Tewary P., de la Rosa G., Yang D. Alarmins initiate host defense. Adv. Exp. Med. Biol. 2007, 601:185-194.
50. Popovic Z.V., Wang S., Papatriantafyllou M., Kaya Z., Porubsky S., Meisner M., Bonrouhi M., Burgdorf S., Young M.F., Schaefer L., Gröne H.J. The proteoglycan biglycan enhances antigen-specific Tcell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis. J.Immunol. 2011, 187:6217-6226.
51. Redondo-Muñoz J., Ugarte-Berzal E., Terol M.J., Van den Steen P.E., Hernández del Cerro M., Roderfeld M., Roeb E., Opdenakker G., García-Marco J.A., García-Pardo A. Matrix metalloproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domain. Cancer Cell 2010, 17:160-172.
52. Rozanov D.V., Sikora S., Godzik A., Postnova T.I., Golubkov V., Savinov A., Tomlinson S., Strongin A.Y. Non-proteolytic, receptor/ligand interactions associate cellular membrane type-1 matrix metalloproteinase with the complement component C1q. J.Biol. Chem. 2004, 279:50321-50328.
53. Rutz M., Metzger J., Gellert T., Luppa P., Lipford G.B., Wagner H., Bauer S. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol. 2004, 34:2541-2550.
54. Saenz S.A., Siracusa M.C., Perrigoue J.G., Spencer S.P., Urban J.F., Tocker J.E., Budelsky A.L., Kleinschek M.A., Kastelein R.A., Kambayashi T., et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010, 464:1362-1366.
55. Sauer A., Rochet E., Lahmar I., Brunet J., Sabou M., Bourcier T., Candolfi E., Pfaff A.W. The local immune response to intraocular Toxoplasma re-challenge: less pathology and better parasite control through Treg/Th1/Th2 induction. Int. J. Parasitol. 2013, 43:721-728.
56. Schaefer L., Babelova A., Kiss E., Hausser H.J., Baliova M., Krzyzankova M., Marsche G., Young M.F., Mihalik D., Götte M., et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J.Clin. Invest. 2005, 115:2223-2233.
57. Schmalfeldt B., Prechtel D., Härting K., Späthe K., Rutke S., Konik E., Fridman R., Berger U., Schmitt M., Kuhn W., Lengyel E. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res. 2001, 7:2396-2404.
58. Seshagiri P.B., Lalitha H.S., Mishra A., Sireesha G.V. Embryo-endometrial proteases during early mammalian development. Indian J. Exp. Biol. 2003, 41:756-763.
59. Siracusa M.C., Saenz S.A., Hill D.A., Kim B.S., Headley M.B., Doering T.A., Wherry E.J., Jessup H.K., Siegel L.A., Kambayashi T., et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 2011, 477:229-233.
60. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., Gilliet M., Ho S., Antonenko S., Lauerma A., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 2002, 3:673-680.
61. Takeda K., Takeuchi O., Akira S. Recognition of lipopeptides by Toll-like receptors. J.Endotoxin Res. 2002, 8:459-463.
62. Vasselon T., Hanlon W.A., Wright S.D., Detmers P.A. Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38. J.Leukoc. Biol. 2002, 71:503-510.
63. Vasselon T., Detmers P.A., Charron D., Haziot A. TLR2 recognizes a bacterial lipopeptide through direct binding. J.Immunol. 2004, 173:7401-7405.
64. Westermarck J., Kähäri V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999, 13:781-792.
65. Wills-Karp M., Rani R., Dienger K., Lewkowich I., Fox J.G., Perkins C., Lewis L., Finkelman F.D., Smith D.E., Bryce P.J., et al. Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection. J.Exp. Med. 2012, 209:607-622.
66. Yang D., Chen Q., Su S.B., Zhang P., Kurosaka K., Caspi R.R., Michalek S.M., Rosenberg H.F., Zhang N., Oppenheim J.J. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J.Exp. Med. 2008, 205:79-90.
67. Zhang Q., O'Hearn S., Kavalukas S.L., Barbul A. Role of highmobility group box 1 (HMGB1) in wound healing. J.Surg. Res. 2012, 176:343-347.